Victoria Aramă *, Dorina Giurcăneanu **, Violeta Molagic ***
* Dr. Victoria Aramă – Medic primar, șef de lucrări, Doctor în științe medicale, Clinica I Boli Infecțioase, Institutul de Boli lnfecțioase “Prof. Dr. M. Balș” București
** Dr. Dorina Giurcăneanu – Medic primar, șef lucrări, Clinica Dermato-venerice, Spitalul Clinic Colentina București
*** Dr. Violeta Molagic – Medic rezident anul V, Clinica I Boli lnfecțioase, Institutul de Boli Infecțioase “Prof. Dr. M. Balș” București
Abstract
Kaposi sarcoma are today the most frequent neoplasm to the immunodeprimated patient with HIV infection or organ transplant recipients. Today it is accepted the involve HHV8 of its pathogenity. The oncogenic mechanism of HHV8 are insufficient known. Skin lesions are most frequent and are easy to diagnostic. The visceral lesions are difficult to diagnostic and they have an reservate prognosis. The therapy of Kaposi sarcoma are complex chemotherapy, radiotherapy, antiviral therapy
and surgical.